These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32385539)

  • 1. Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping.
    Réant P; Testet E; Reynaud A; Bourque C; Michaud M; Rooryck C; Goizet C; Lacombe D; de-Précigout V; Peyrou J; Cochet H; Lafitte S
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1333-1342. PubMed ID: 32385539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
    Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Clinical Evolution in Prehypertrophic Fabry Disease.
    Camporeale A; Pieroni M; Pieruzzi F; Lusardi P; Pica S; Spada M; Mignani R; Burlina A; Bandera F; Guazzi M; Graziani F; Crea F; Greiser A; Boveri S; Ambrogi F; Lombardi M
    Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008424. PubMed ID: 30943767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease.
    Spinelli L; Giugliano G; Imbriaco M; Esposito G; Nappi C; Riccio E; Ponsiglione A; Pisani A; Cuocolo A; Trimarco B
    Int J Cardiovasc Imaging; 2020 Aug; 36(8):1465-1476. PubMed ID: 32306159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
    Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status.
    Morris DA; Blaschke D; Canaan-Kühl S; Krebs A; Knobloch G; Walter TC; Haverkamp W
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):301-13. PubMed ID: 25315709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients.
    Esposito R; Galderisi M; Santoro C; Imbriaco M; Riccio E; Maria Pellegrino A; Sorrentino R; Lembo M; Citro R; Angela Losi M; Spinelli L; Trimarco B; Pisani A
    Eur Heart J Cardiovasc Imaging; 2019 Apr; 20(4):438-445. PubMed ID: 30085001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
    Augusto JB; Johner N; Shah D; Nordin S; Knott KD; Rosmini S; Lau C; Alfarih M; Hughes R; Seraphim A; Vijapurapu R; Bhuva A; Lin L; Ojrzyńska N; Geberhiwot T; Captur G; Ramaswami U; Steeds RP; Kozor R; Hughes D; Moon JC; Namdar M
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):790-799. PubMed ID: 32514567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.
    Kozor R; Nordin S; Treibel TA; Rosmini S; Castelletti S; Fontana M; Captur G; Baig S; Steeds RP; Hughes D; Manisty C; Grieve SM; Figtree GA; Moon JC
    Eur Heart J Cardiovasc Imaging; 2017 Sep; 18(9):1034-1040. PubMed ID: 27590835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
    Vijapurapu R; Nordin S; Baig S; Liu B; Rosmini S; Augusto J; Tchan M; Hughes DA; Geberhiwot T; Moon JC; Steeds RP; Kozor R
    Heart; 2019 Mar; 105(6):470-476. PubMed ID: 30282640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
    Nordin S; Kozor R; Vijapurapu R; Augusto JB; Knott KD; Captur G; Treibel TA; Ramaswami U; Tchan M; Geberhiwot T; Steeds RP; Hughes DA; Moon JC
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009430. PubMed ID: 31826677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
    Augusto JB; Nordin S; Vijapurapu R; Baig S; Bulluck H; Castelletti S; Alfarih M; Knott K; Captur G; Kotecha T; Ramaswami U; Tchan M; Geberhiwot T; Fontana M; Steeds RP; Hughes D; Kozor R; Moon JC
    Circ Cardiovasc Imaging; 2020 Mar; 13(3):e010171. PubMed ID: 32114828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Phenotype of Prehypertrophic Fabry Disease.
    Nordin S; Kozor R; Baig S; Abdel-Gadir A; Medina-Menacho K; Rosmini S; Captur G; Tchan M; Geberhiwot T; Murphy E; Lachmann R; Ramaswami U; Edwards NC; Hughes D; Steeds RP; Moon JC
    Circ Cardiovasc Imaging; 2018 Jun; 11(6):e007168. PubMed ID: 29853467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T₁ mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.
    Thompson RB; Chow K; Khan A; Chan A; Shanks M; Paterson I; Oudit GY
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):637-45. PubMed ID: 23922004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fractal dimension of left ventricular trabeculations is associated with subclinical diastolic dysfunction in patients with type-2 diabetes mellitus.
    Shang Y; Zhang X; Leng W; Lei X; Chen L; Zhou X; Chow K; Shi Y; Dong J; Liang Z; Wang J
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):665-673. PubMed ID: 30430327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.
    Phelan D; Collier P; Thavendiranathan P; Popović ZB; Hanna M; Plana JC; Marwick TH; Thomas JD
    Heart; 2012 Oct; 98(19):1442-8. PubMed ID: 22865865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hypertrophic cardiomyopathy according to global, regional, and multi-layer longitudinal strain analysis, and prediction of sudden cardiac death.
    Vergé MP; Cochet H; Reynaud A; Morlon L; Peyrou J; Vincent C; Rooryck C; Ritter P; Lafitte S; Réant P
    Int J Cardiovasc Imaging; 2018 Jul; 34(7):1091-1098. PubMed ID: 29488042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease.
    Palecek T; Linhart A; Lubanda JC; Magage S; Karetova D; Bultas J; Aschermann M
    Heart Vessels; 2006 Jan; 21(1):13-9. PubMed ID: 16440143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.